Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this week’s Pathways Picks: India amends its regulations to further rely on EU CE marks, and makes other simplifications; Brazil issues in-depth submission guides; Germany addresses health app modifications; FDA picks first two firms for the READI-Home Innovation Challenge; Taiwan advances eSubmissions; and more medtech policy updates.
Despite geopolitical challenges and fierce competition for capital, the medtech investment market has maintained the momentum from 2025 through 2026, according to PwC’s latest medtech deals outlook.
The agency outlines new centralized operations. Excerpted from Pathways Picks July 29: FDA Consolidation, User Fees Rise, South Korea Streamlines .